| 1 |
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
Johannes Alfred Witjes, Harman Max Bruins, Richard L. Cathomas et al. · European Urology
|
29 Apr 2020 |
2,175 |
| 2 |
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Nicholas David James et al. · The Lancet
Open access |
21 Dec 2015 |
1,985 |
| 3 |
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
Jaafar Bennouna, Javier Sastre, Dirk Arnold et al. · The Lancet Oncology
Open access |
15 Nov 2012 |
1,175 |
| 4 |
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Philippe Moreau, Jesús F. San Miguel, Pieter Sonneveld et al. · Annals of Oncology
Open access |
6 Apr 2017 |
882 |
| 5 |
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
Meletios Athanasios Dimopoulos, Philippe Moreau, Evangelos Terpos et al. · Annals of Oncology
Open access |
5 Feb 2021 |
850 |
| 6 |
Normal values for cardiovascular magnetic resonance in adults and children
Nadine Kawel‐Boehm, Alicia M. Maceira, Emanuela R. Valsangiacomo Buechel et al. · Journal of Cardiovascular Magnetic Resonance
Open access |
2015 |
781 |
| 7 |
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
Johannes Alfred Witjes et al. · European Urology
Open access |
17 Oct 2023 |
665 |
| 8 |
Reference ranges (“normal values”) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update
Nadine Kawel‐Boehm, Scott Hetzel, Bharath Ambale‐Venkatesh et al. · Journal of Cardiovascular Magnetic Resonance
Open access |
2020 |
624 |
| 9 |
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Barbara F. Eichhorst, Tadeusz Robak, Emili Montserrat et al. · Annals of Oncology
Open access |
19 Oct 2020 |
588 |
| 10 |
Guidelines for the clinical application of the LCP
Emanuel Gautier, Christoph Markus Sommer · Injury
|
22 Oct 2003 |
568 |
| 11 |
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
Rafael Cardoso et al. · The Lancet Oncology
Open access |
25 May 2021 |
496 |
| 12 |
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study
Susan M. Domchek et al. · The Lancet Oncology
Open access |
6 Aug 2020 |
478 |
| 13 |
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
Caroline Voskens et al. · PLoS ONE
Open access |
14 Jan 2013 |
472 |
| 14 |
Current best practice for bladder cancer: a narrative review of diagnostics and treatments
Éva Compérat, Mahul B. Amin, Richard L. Cathomas et al. · The Lancet
ReviewOpen access |
26 Sep 2022 |
460 |
| 15 |
Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)
Nicholas David James, Melissa Ruth Spears, Noel William Clarke et al. · European Urology
Open access |
7 Oct 2014 |
440 |
| 16 |
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
Miklos Pless et al. · The Lancet
Open access |
11 Aug 2015 |
394 |
| 17 |
The epidemiology of fractures of the distal femur
Olivier Martinet, J. Cordey, Yves Harder et al. · Injury
|
Sep 2000 |
376 |
| 18 |
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Klaus‐Peter Dieckmann et al. · Journal of Clinical Oncology
Open access |
15 Mar 2019 |
354 |
| 19 |
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial
Sacha I. Rothschild et al. · Journal of Clinical Oncology
Open access |
12 Jul 2021 |
350 |
| 20 |
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
Martin J. van den Bent et al. · The Lancet Oncology
Open access |
14 May 2021 |
334 |
| 21 |
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Friedemann U. Honecker et al. · Annals of Oncology
Open access |
18 Jun 2018 |
331 |
| 22 |
First clinical results of the Locking Compression Plate (LCP)
Christoph Markus Sommer, Emanuel Gautier, Matthias Müller et al. · Injury
|
22 Oct 2003 |
329 |
| 23 |
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
J. Beyer et al. · Annals of Oncology
Open access |
14 Nov 2012 |
323 |
| 24 |
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study
the Swiss HIV Cohort Study et al. · British Journal of Cancer
Open access |
29 Jun 2010 |
307 |
| 25 |
Trochleaplasty for recurrent patellar dislocation in association with trochlear dysplasia
Fabian von Knoch, T Böhm, Martin Burgi et al. · Journal of Bone and Joint Surgery - British Volume
Open access |
29 Sep 2006 |
280 |
| 26 |
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol
Matthew Robert Sydes et al. · Annals of Oncology
Open access |
20 Feb 2018 |
253 |
| 27 |
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
Julie J. Miller et al. · Neuro-Oncology
Open access |
24 Aug 2022 |
252 |
| 28 |
Catamenial pneumothorax revisited: Clinical approach and systematic review of the literature
Stephan Korom, Haydar Canyurt, Antje Missbach et al. · Journal of Thoracic and Cardiovascular Surgery
ReviewOpen access |
24 Sep 2004 |
237 |
| 29 |
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
Alexandros Papachristofilou et al. · Journal for ImmunoTherapy of Cancer
Open access |
8 Feb 2019 |
230 |
| 30 |
How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists
Zsuzsanna Varga, Joachim Diebold, Corina C. Dommann-Scherrer et al. · PLoS ONE
Open access |
25 May 2012 |
227 |
| 31 |
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
Antoine G. van der Heijden et al. · European Urology
Open access |
20 Mar 2025 |
219 |
| 32 |
European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making
Nicolaus H. Andratschke, Jonas Willmann, Ane Lindegaard Appelt et al. · The Lancet Oncology
Open access |
26 Sep 2022 |
212 |
| 33 |
Effect of High Intensity Exercise Training on Central Hemodynamic Responses to Exercise in Men With Reduced Left Ventricular Function
Paul Dubach, JONATHAN N. MYERS, Gerald Dziekan et al. · Journal of the American College of Cardiology
Open access |
Jun 1997 |
206 |
| 34 |
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial
Rolf Arno Stahel et al. · The Lancet Oncology
|
4 Nov 2015 |
203 |
| 35 |
The Relationship of Left Ventricular Trabeculation to Ventricular Function and Structure Over a 9.5-Year Follow-Up
Filip Zemrak, Mark A. Ahlman, Gabriella Captur et al. · Journal of the American College of Cardiology
Open access |
Nov 2014 |
199 |
| 36 |
Operative versus nonoperative treatment of proximal humeral fractures: a systematic review, meta-analysis, and comparison of observational studies and randomized controlled trials
Reinier B. Beks, Yassine Ochen, Herman Frima et al. · Journal of Shoulder and Elbow Surgery
ReviewOpen access |
3 May 2018 |
198 |
| 37 |
Trochleaplasty for patellar instability due to trochlear dysplasia
Philip B. Schöttle, Sandro F. Fucentese, Christian W. A. Pfirrmann et al. · Acta Orthopaedica
Open access |
2005 |
198 |
| 38 |
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†
Johannes Alfred Witjes et al. · European Urology
Open access121 authors |
19 Nov 2019 |
194 |
| 39 |
THE TRANSITIONAL VERTEBRA OF THE LUMBOSACRAL SPINE: ITS RADIOLOGICAL CLASSIFICATION, INCIDENCE, PREVALENCE, AND CLINICAL SIGNIFICANCE
Paolo Tini, C Wieser, W M Zinn · Lara D. Veeken
|
1977 |
194 |
| 40 |
Preventing CKD in Developed Countries
Valérie A. Luyckx, David Z.I. Cherney, Aminu K. Bello · Kidney International Reports
Open access |
18 Dec 2019 |
188 |
| 41 |
Thoracotomy and thoracoscopy: postoperative pulmonary function, pain and chest wall complaints
Markus Furrer, Renate Rechsteiner, Verena Eigenmann et al. · European Journal of Cardio-Thoracic Surgery
Open access |
Jul 1997 |
187 |
| 42 |
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees
Alan Horwich et al. · Annals of Oncology
Open access121 authors |
30 Aug 2019 |
183 |
| 43 |
Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors
David H. Henry, Saroj Vadhan‐Raj, Vera Hirsh et al. · Supportive Care in Cancer
Open access |
25 Oct 2013 |
182 |
| 44 |
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
Stephanie G. C. Kroeze et al. · The Lancet Oncology
ReviewOpen access |
27 Feb 2023 |
181 |
| 45 |
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
Martin Schüler et al. · The Lancet Oncology
|
9 Aug 2019 |
181 |
| 46 |
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
J. Beyer et al. · Journal of Clinical Oncology
Open access |
23 Mar 2021 |
178 |
| 47 |
Endovascular Treatment of Common Femoral Artery Disease
Robert Francis Bonvini, Aljoscha Rastan, Sebastian Sixt et al. · Journal of the American College of Cardiology
Open access |
Aug 2011 |
172 |
| 48 |
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆
Pierre Fenaux, Dagmar Haase, Valeria Santini et al. · Annals of Oncology
Open access |
19 Nov 2020 |
171 |
| 49 |
Endothelin-1 in Pulmonary Hypertension Associated With High-Altitude Exposure
Stefan Goerre, Markus Rene Wenk, Peter Bärtsch et al. · Circulation
|
15 Jan 1995 |
170 |
| 50 |
Prospective validation of classification of intraoperative adverse events (ClassIntra): international, multicentre cohort study
Salome Dell‐Kuster et al. · BMJ
Open access |
25 Aug 2020 |
169 |